Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Assets (2016 - 2025)

Historic Assets for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $30.7 million.

  • Dare Bioscience's Assets rose 7026.92% to $30.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.7 million, marking a year-over-year increase of 7026.92%. This contributed to the annual value of $22.1 million for FY2024, which is 384.79% up from last year.
  • As of Q3 2025, Dare Bioscience's Assets stood at $30.7 million, which was up 7026.92% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Assets ranged from a high of $55.8 million in Q4 2021 and a low of $10.5 million during Q1 2021
  • Its 5-year average for Assets is $29.7 million, with a median of $23.6 million in 2024.
  • In the last 5 years, Dare Bioscience's Assets surged by 63909.82% in 2021 and then plummeted by 5714.8% in 2024.
  • Dare Bioscience's Assets (Quarter) stood at $55.8 million in 2021, then decreased by 21.47% to $43.8 million in 2022, then crashed by 51.44% to $21.3 million in 2023, then grew by 3.85% to $22.1 million in 2024, then surged by 39.13% to $30.7 million in 2025.
  • Its Assets stands at $30.7 million for Q3 2025, versus $13.0 million for Q2 2025 and $18.6 million for Q1 2025.